| scholarly article | Q13442814 |
| P50 | author | Andrew D. Clouston | Q38548319 |
| Elizabeth Powell | Q42597946 | ||
| P2093 | author name string | David M Purdie | |
| Michelle M Richardson | |||
| Julie R Jonsson | |||
| Meagan J Walsh | |||
| Daina M Vanags | |||
| P2860 | cites work | Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction | Q25938986 |
| Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis | Q29619627 | ||
| Involvement of Fas system-mediated apoptosis in pathogenesis of viral hepatitis | Q33801352 | ||
| Nonalcoholic steatosis and steatohepatitis IV. Nonalcoholic fatty liver disease abnormalities in macrophage function and cytokines | Q34467338 | ||
| Death receptor-mediated apoptosis and the liver | Q34783540 | ||
| Triglyceride accumulation protects against fatty acid-induced lipotoxicity | Q34866329 | ||
| Lipoapoptosis: its mechanism and its diseases | Q35047180 | ||
| Apoptosis in hepatitis C virus infection | Q35091473 | ||
| Effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis C. | Q35594723 | ||
| Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies. | Q35598407 | ||
| Protection against lipoapoptosis of beta cells through leptin-dependent maintenance of Bcl-2 expression | Q36266492 | ||
| Classification of chronic viral hepatitis: a need for reassessment | Q37032966 | ||
| TUNEL apoptotic cell detection in tissue sections: critical evaluation and improvement | Q38472345 | ||
| Hepatitis C virus core protein inhibits Fas- and tumor necrosis factor alpha-mediated apoptosis via NF-kappaB activation | Q39594009 | ||
| Fas enhances fibrogenesis in the bile duct ligated mouse: a link between apoptosis and fibrosis. | Q39632325 | ||
| Characterisation of the differences between hepatitis C virus genotype 3 and 1 glycoproteins. | Q40645144 | ||
| Hepatitis C virus core protein induces apoptosis and impairs cell-cycle regulation in stably transformed Chinese hamster ovary cells | Q40877562 | ||
| Suppression of apoptotic cell death by hepatitis C virus core protein | Q41145136 | ||
| In overweight patients with chronic hepatitis C, circulating insulin is associated with hepatic fibrosis: implications for therapy. | Q42981587 | ||
| Sensitization to Fas-mediated apoptosis by hepatitis C virus core protein | Q42982436 | ||
| Liver cell apoptosis in chronic hepatitis C correlates with histological but not biochemical activity or serum HCV-RNA levels | Q42998514 | ||
| Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3. | Q42999424 | ||
| Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity | Q43031928 | ||
| Steatosis accelerates fibrosis development over time in hepatitis C virus genotype 3 infected patients | Q43041131 | ||
| The mechanisms underlying hepatitis C virus genotype 3-mediated liver damage | Q43047606 | ||
| Real-time reverse transcriptase-polymerase chain reaction (RT-PCR) for measurement of cytokine and growth factor mRNA expression with fluorogenic probes or SYBR Green I. | Q43623003 | ||
| Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: evidence that beta-cell death is caspase mediated, partially dependent on ceramide pathway, and Bcl-2 regulated. | Q43972538 | ||
| Steatosis in chronic hepatitis C: relative contributions of obesity, diabetes mellitus, and alcohol | Q44116657 | ||
| Caspase activation correlates with the degree of inflammatory liver injury in chronic hepatitis C virus infection | Q45735446 | ||
| Obesity and its nurturing effect on hepatitis C. | Q53919637 | ||
| Detection of male DNA in the liver of female patients with primary biliary cirrhosis | Q61895905 | ||
| Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis | Q73735584 | ||
| Lymphocyte apoptosis and cell replacement in human liver allografts | Q74365724 | ||
| Anti-Fas induces hepatic chemokines and promotes inflammation by an NF-kappa B-independent, caspase-3-dependent pathway | Q74623251 | ||
| Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis | Q74645276 | ||
| Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression | Q79209033 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | steatosis | Q1365091 |
| hepatitis C | Q154869 | ||
| apoptotic process | Q14599311 | ||
| chronic hepatitis C | Q55779873 | ||
| chronic hepatitis | Q62019625 | ||
| P304 | page(s) | 1230-1238 | |
| P577 | publication date | 2004-05-01 | |
| P1433 | published in | Hepatology | Q15724398 |
| P1476 | title | Steatosis and liver cell apoptosis in chronic hepatitis C: a mechanism for increased liver injury | |
| P478 | volume | 39 |
| Q40279228 | 17 Beta-estradiol prevents cytotoxicity from hydrophobic bile acids in HepG2 and WRL-68 cell cultures |
| Q26770432 | A Meta-Analysis of the Association Between the I148M Variant of Patatin-Like Phospholipase Domain Containing 3 Gene and the Presence of Chronic Hepatitis C |
| Q58697388 | A nonalcoholic fatty liver disease model in human induced pluripotent stem cell-derived hepatocytes, created by endoplasmic reticulum stress-induced steatosis |
| Q37050079 | Adiponectin and its receptors in chronic hepatitis B patients with steatosis in china |
| Q80867459 | An apoptosis biomarker goes to the HCV clinic |
| Q33909978 | Anti-apoptotic and antioxidant effect of leptin on CCl₄-induced acute liver injury in rats |
| Q27490338 | Apoptosis in animal models of virus-induced disease |
| Q36669223 | Beyond insulin resistance: Innate immunity in nonalcoholic steatohepatitis |
| Q28468601 | Biochemical mechanism underlying hypertriglyceridemia and hepatic steatosis/hepatomegaly induced by acute schisandrin B treatment in mice |
| Q37776184 | Cell Death and Fibrogenesis |
| Q35165949 | Changes in lipid metabolism in chronic hepatitis C. |
| Q38157936 | Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations |
| Q35045338 | Correlation of serum leptin levels with anthropometric and metabolic parameters and biochemical liver function in Chinese patients with chronic hepatitis C virus infection |
| Q27482253 | Cre-estrogen receptor-mediated hepatitis C virus structural protein expression in mice |
| Q37903853 | Current understanding of insulin resistance in hepatitis C. |
| Q36967102 | Elevated serum CK18 levels in chronic hepatitis C patients are associated with advanced fibrosis but not steatosis. |
| Q27485351 | Exploring differences in response to treatment with peginterferon alpha 2a (40kD) and ribavirin in chronic hepatitis C between genotypes 2 and 3 |
| Q42991520 | Fibrosis correlates with a ductular reaction in hepatitis C: roles of impaired replication, progenitor cells and steatosis |
| Q39302599 | Free fatty acids induce ER stress and block antiviral activity of interferon alpha against hepatitis C virus in cell culture |
| Q34699457 | HIV infection increases HCV-induced hepatocyte apoptosis |
| Q42203551 | Hepatic expression of miR-122, miR-126, miR-136 and miR-181a and their correlation to histopathological and clinical characteristics of patients with hepatitis C. |
| Q36382231 | Hepatitis C -- identifying patients with progressive liver injury |
| Q41867049 | Hepatitis C Virus Infection Increases c-Jun N-Terminal Kinase (JNK) Phosphorylation and Accentuates Hepatocyte Lipoapoptosis. |
| Q36377276 | Hepatitis C and steatosis: a reappraisal |
| Q37386098 | Hepatitis C virus and glucose and lipid metabolism |
| Q24658049 | Hepatitis C virus and type 2 diabetes |
| Q36749431 | Hepatitis C virus infection--pathobiology and implications for new therapeutic options |
| Q36634377 | Histological assessment of non-alcoholic fatty liver disease |
| Q45363028 | IL-22 and non-ELR-CXC chemokine expression in chronic hepatitis B virus-infected liver |
| Q37852704 | IRS2 and PTP1B: Two opposite modulators of hepatic insulin signalling. |
| Q36490255 | Impact of obesity on treatment of chronic hepatitis C. |
| Q83846277 | Impact of patatin-like phospholipase-3 (rs738409 C>G) polymorphism on fibrosis progression and steatosis in chronic hepatitis C |
| Q88881039 | Insulin resistance and its consequences in chronic hepatitis C |
| Q37201550 | Insulin resistance and necroinflammation drives ductular reaction and epithelial-mesenchymal transition in chronic hepatitis C. |
| Q36160709 | Insulin resistance and steatosis in hepatitis C virus infection. |
| Q34074149 | Is There a Potential Role for Anti-tumor Necrosis Factor Therapy in Patients with Human Immunodeficiency Virus? |
| Q40092587 | Lack of Fas antagonism by Met in human fatty liver disease |
| Q38008400 | Mechanisms and biomarkers of apoptosis in liver disease and fibrosis |
| Q33866272 | Mechanisms and significance of liver steatosis in hepatitis C virus infection |
| Q42123455 | Melatonin in the regulation of liver steatosis following prenatal glucocorticoid exposure. |
| Q27011787 | Metabolic factors and chronic hepatitis C: a complex interplay |
| Q40122130 | Microarray analyses and molecular profiling of steatosis induction in immortalized human hepatocytes |
| Q45325177 | Modulation of Cell Death Pathways by Hepatitis C Virus Proteins in Huh7.5 Hepatoma Cells. |
| Q45369635 | No evidence of the unfolded protein response in patients with chronic hepatitis C virus infection |
| Q27478313 | Non-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype 1 |
| Q61895898 | Obesity and steatosis influence serum and hepatic inflammatory markers in chronic hepatitis C |
| Q40312537 | Paradoxical effects of short- and long-term interleukin-6 exposure on liver injury and repair. |
| Q34860648 | Parenchymal expression of CD40 exacerbates adenovirus-induced hepatitis in mice. |
| Q27022707 | Pathophysiology of insulin resistance and steatosis in patients with chronic viral hepatitis |
| Q48591916 | Quantification of portal-bridging fibrosis area more accurately reflects fibrosis stage and liver stiffness than whole fibrosis or perisinusoidal fibrosis areas in chronic hepatitis C. |
| Q36286323 | Review article: an unexpected virus-host interaction--the hepatitis C virus-diabetes link |
| Q42870806 | Steatosis as a co-factor in chronic liver diseases |
| Q36165987 | Steatosis: co-factor in other liver diseases. |
| Q81446455 | The accuracy of sonography in predicting steatosis and fibrosis in chronic hepatitis C |
| Q45457722 | The extent of liver steatosis in chronic hepatitis C virus infection is mirrored by caspase activity in serum |
| Q90076021 | The role of cellular prion protein in lipid metabolism in the liver |
| Q82663340 | Vulnerability of experimentally induced fatty liver to heat stress in rats |
| Q80066082 | [Can metabolic steatohepatitis be treated?] |
| Q83868802 | [Liver apoptosis] |
Search more.